Back

Atrial dysfunction in isolated atrial amyloidosis: a pathological and echocardiographic perspectives

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cross-modality imaging for diagnosis and prognosis Imaging of Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Shun Nishino

Miyazaki Medical Association Hospital, Cardiovascular Center, Miyazaki (Japan)

5 More presentations in this session

Presentation thumbnail
Redefining aortic root assessment: standardising the maximum cusp-to-cusp diameter in multimodality imaging
Doctor A. Hernandez-Pineda (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Biologically older cardiovascular system predicts adverse clinical outcome independently of chronological age.
Mr A. Mohamed (London, GB)
Abstract Slides Video
Presentation thumbnail
Association between fragmented QRS, myocardial scar burden and left ventricular function: a multimodality imaging study
Doctor S. Mijatovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Association of lipoprotein(a) with coronary plaque progression in patients with acute coronary syndrome assessed by optical coherence tomography
Doctor F. Dong (Harbin, CN)
Abstract Slides Video
Presentation thumbnail
Use of coronary computed tomography angiography in Greece insights from the real world, multicenter COCOA-GR COronary COmputed Tomography Angiography GReece registry
Doctor S. Simantiris (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Cross-modality imaging for diagnosis and prognosis
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Left atrial function and the risk of new-onset atrial fibrillation in cardiac amyloidosis
thumbnail
Congress Presentation
Left atrial reservoir strain differentiates cardiac amyloidosis and hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Trends in prevalence and clinical outcomes of patients with atrial fibrillation and cardiac amyloidosis- from a nationwide registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources